Eggimann, M.; Akhoundova, D.; Nilius, H.; Hoffmann, M.; Hayoz, M.; Aebi, Y.; Largiadèr, C.R.; Daskalakis, M.; Bacher, U.; Pabst, T.
Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation. Cancers 2024, 16, 1887.
https://doi.org/10.3390/cancers16101887
AMA Style
Eggimann M, Akhoundova D, Nilius H, Hoffmann M, Hayoz M, Aebi Y, Largiadèr CR, Daskalakis M, Bacher U, Pabst T.
Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation. Cancers. 2024; 16(10):1887.
https://doi.org/10.3390/cancers16101887
Chicago/Turabian Style
Eggimann, Matthias, Dilara Akhoundova, Henning Nilius, Michèle Hoffmann, Michael Hayoz, Yolanda Aebi, Carlo R. Largiadèr, Michael Daskalakis, Ulrike Bacher, and Thomas Pabst.
2024. "Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation" Cancers 16, no. 10: 1887.
https://doi.org/10.3390/cancers16101887
APA Style
Eggimann, M., Akhoundova, D., Nilius, H., Hoffmann, M., Hayoz, M., Aebi, Y., Largiadèr, C. R., Daskalakis, M., Bacher, U., & Pabst, T.
(2024). Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation. Cancers, 16(10), 1887.
https://doi.org/10.3390/cancers16101887
